Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity
about
Model-Based Optimisation of Deferoxamine Chelation Therapy.Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
P2860
Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@ast
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@en
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@nl
type
label
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@ast
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@en
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@nl
prefLabel
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@ast
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@en
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@nl
P2093
P356
P1476
Comparison of deferoxamine pha ...... xhibiting severe neurotoxicity
@en
P2093
P304
P356
10.1038/CLPT.1990.60
P407
P577
1990-04-01T00:00:00Z